Immunotherapies Archives - Page 2 of 3 - Australian Biotech Company News

Home Tags Immunotherapies

Biotechnology

Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice

BioChannel - February 13, 2020

Biotechnology

OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung Cancer

BioChannel - January 24, 2020

Biotechnology

“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types

BioChannel - January 23, 2020

Biotechnology

Astellas Acquires Xyphos for Up to $665M, Boosting Cancer Immunotherapy Pipeline

BioChannel - December 27, 2019

Biotechnology

Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen...

BioChannel - December 9, 2019

Biotechnology

Tocagen Axing 65% of Staff after Cancer Immunotherapy Combination Fails Phase...

BioChannel - October 4, 2019

Biotechnology

Breathalyzer Sniffs Out Potential Cancer Immunotherapy Responders

BioChannel - September 18, 2019

Biotechnology

Breakthroughs in Immunotherapy

BioChannel - September 12, 2019

Biotechnology

Celgene, Immatics Launch Up-to-$1.5B+ Cancer T-Cell Collaboration

BioChannel - August 28, 2019

Biotechnology

Microbiomes of Lab Mice Take a Walk on the Wild Side

BioChannel - August 2, 2019

123 Page 2 of 3

Stay connected

Recent posts

Researchers create first comprehensive functional map of genes expressed in human cells

BioChannel - June 9, 2022

Are we born with a moral compass?

BioChannel - June 9, 2022

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery methods

BioChannel - June 9, 2022

Random article

Researchers create first comprehensive functional map of genes expressed in human...

Are we born with a moral compass?

Ziphius Vaccines and University of Antwerp to work on RNA-based delivery...

Alzheimer’s Pathology Could Benefit from Activating Microglial Targets of Rapamycin